Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years

Clinical Infectious Diseases

Volumn 24, Issue 4, 1997, Pages 684-703

  Berman, J D ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B LIPID COMPLEX; ANTIMONY; MEGLUMINE ANTIMONATE; PAROMOMYCIN; PENTAMIDINE; STIBOGLUCONATE SODIUM;

CHEMOTHERAPY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG FORMULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEISHMANIA BRAZILIENSIS; LEISHMANIA MAJOR; LEISHMANIASIS; LYSOSOME; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; TOPICAL DRUG ADMINISTRATION;

EID: 0030940539     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clind/24.4.684     Document Type: Review

References (23)

1. Ashford RW, Desjeux P, deRaadt P. Estimation of population at risk of infection and number of cases of leishmaniasis. Parasitology Today 1992;8:104-5.
2. Berman JD. Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies. Rev Infect Dis 1988;10: 560-86.
3. Davidson RN, Croft SL. Recent advances in the treatment of visceral leishmaniasis. Trans R Soc Trop Med Hyg 1993;87:130-1.
4. Olliaro PL, Bryceson ADM. Practical progress and new drugs for changing patterns of leishmaniasis. Parasitology Today 1993;9:323-8.
5. Grimaldi G Jr, Tesh RB, McMahon-Pratt D. A review of the geographic distribution and epidemiology of leishmaniasis in the new world. Am J Trop Med Hyg 1989;41:687-725.
6. Dietze R, Milan EP, Berman ID, et al. Treatment of Brazilian kala-azar with a short course of Amphocil (amphotericin B cholesterol dispersion). Clin Infect Dis 1993;17:981-6.
7. Hashim FA, Ali MS, Satti M, et al. An outbreak of acute kala-azar in a nomadic tribe in western Sudan: features of the disease in a previously non-immune population. Trans R Soc Trop Med Hyg 1994;88: 431-2.
8. Hervás JA, Alberti P, Ferragut J, Canet R. Acute hepatitis as a presenting manifestation of kala-azar. Pediatr Infect Dis J 1991;10:409-10.
9. Garcés JM, Tomás S, Rubiés-Prat J, Gimeno JL, Drobnic L. Bacterial infection as a presenting manifestation of visceral leishmaniasis. Rev Infect Dis 1990;12:518-9.
10. Fasanaro AM, Scoleri G, Pizza V, Gaeta GB, Fasanaro A. Guillain-Barré syndrome as presenting manifestation of visceral leishmaniasis [letter]. Lancet 1991;338:1142.
11. Seaman J, Mercer AJ, Sondorp HE, Herwaldt BL. Epidemic visceral leishmaniasis in southern Sudan: treatment of severely debilitated patients under wartime conditions and with limited resources. Ann Intern Med 1996;124:664-72.
12. Thakur CP, Sinha GP, Pandey AK, Barat D, Sinha PK. Amphotericin B in resistant kala-azar in Bihar. Natl Med J India 1993;6:57-60.
13. Magill AJ, Grögl M, Gasser RA Jr, Sun W, Oster CN. Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med 1993;328:1383-7.
14. Magill AJ, Grogl M, Johnson SC, Gasser RA Jr. Visceral infection due to Leishmania tropica in a veteran of Operation Desert Storm who presented 2 years after leaving Saudi Arabia [letter]. Clin Infect Dis 1994;19:805-6.
15. Badaro R, Jones TC, Carvalho EM, et al. New perspectives on a subclinical form of visceral leishmaniasis. J Infect Dis 1986;154:1003-11.
16. Alvar J. Leishmaniasis and AIDS co-infection: the Spanish example. Parasitology Today 1994;10:160-3.
17. Montalban C, Martinez-Femandez R, Calleja JL, et al. Visceral leishmaniasis (kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain. Rev Infect Dis 1989; 11:655-60.
18. Laguna F, Garcia-Samaniego J, Soriano V, et al. Gastrointestinal leishmaniasis in human immunodeficiency virus-infected patients: report of five cases and review. Clin Infect Dis 1994;19:48-53.
19. Gutiérrez-Macias A, Alonso-Alonso JJ, Aguirre-Errasti C. Esophageal leishmaniasis in a patient infected with the human immunodeficiency virus [letter]. Clin Infect Dis 1995;21:229-30.
20. Rosenthal PJ, Chaisson RE, Hadley WK, Leech JH. Rectal leishmaniasis in a patient with acquired immunodeficiency syndrome. Am J Med 1988;84:307-9.
21. Berenguer J, Moreno S, Cercenado E, Bernaldo de Quirós JCL, Garcia de la Fuente A, Bouza E. Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV). Ann Intern Med 1989; 111:129-32.
22. Rosenthal E, Marty P, Poizot-Martin I, et al. Visceral leishmaniasis and HIV-1 co-infection in southern France. Trans R Soc Trop Med Hyg 1995:89:159-62.
23. Altés J, Salas A, Riera M, et al. Visceral leishmaniasis: another HIV-associated opportunistic infection? Report of eight cases and review of the literature. AIDS 1991;5:201-7.